Cargando…

Molecular Subtyping and Precision Medicine for Pancreatic Cancer

Substantial progress in recent years has dramatically increased our knowledge of the molecular basis of cancer, revealing new potential therapeutic targets and paving the way for effective personalised medicine for the treatment of many tumour types. However, pancreatic cancer has been lagging behin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Froeling, Fieke E. M., Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V., Chang, David K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794969/ https://www.ncbi.nlm.nih.gov/pubmed/33406790 http://dx.doi.org/10.3390/jcm10010149

Ejemplares similares

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
por: Casolino, Raffaella, et al.
Publicado: (2021)

Impact of COVID-19 on Pancreatic Cancer Research and the Path Forward
por: Casolino, Raffaella, et al.
Publicado: (2021)

Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
por: Dreyer, Stephan B., et al.
Publicado: (2022)

The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2023)

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
por: Bryce, Adam S., et al.
Publicado: (2022)

COVID-19 provides an opportunity to transform cancer research
por: Casolino, Raffaella, et al.
Publicado: (2021)

Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
por: Casolino, Raffaella, et al.
Publicado: (2022)

Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake
por: Golan, Talia, et al.
Publicado: (2023)

Subtyping or not subtyping—Quo vadis for precision medicine of colorectal cancer
por: Avagyan, Susanna, et al.
Publicado: (2023)

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer
por: Pan, Chun‐Hao, et al.
Publicado: (2020)

Defining the clinical genomic landscape for real-world precision oncology
por: Beer, Philip A., et al.
Publicado: (2020)

Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
por: Wu, Yichao, et al.
Publicado: (2020)

HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
por: Brunton, Holly, et al.
Publicado: (2020)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors
por: Pulvirenti, Alessandra, et al.
Publicado: (2020)

Precision medicine for suicidality: from universality to subtypes and personalization
por: Niculescu, A B, et al.
Publicado: (2017)

Precision Medicine: Disease Subtyping and Tailored Treatment
por: Wang, Richard C., et al.
Publicado: (2023)

Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq
por: He, Lishu
Publicado: (2021)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
por: Miyabayashi, Koji, et al.
Publicado: (2021)

Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou, Xu, et al.
Publicado: (2021)

Molecular Subtypes and Precision Oncology in Intrahepatic Cholangiocarcinoma
por: Czauderna, Carolin, et al.
Publicado: (2021)

Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2020)

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
por: Sereti, Evangelia, et al.
Publicado: (2023)

Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma
por: Chen, Hao, et al.
Publicado: (2022)

Precision Medicine in Pancreatitis: The Future of Acute Pancreatitis Care
por: Garami, Andras, et al.
Publicado: (2023)

Precision Subtypes of T Cell-Mediated Rejection Identified by Molecular Profiles
por: Kadota, Paul Ostrom, et al.
Publicado: (2015)

Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
por: Zhou, Xu, et al.
Publicado: (2023)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

Artificial intelligence, molecular subtyping, biomarkers, and precision oncology
por: Shen, John Paul
Publicado: (2021)

Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
por: Riva, Giulio, et al.
Publicado: (2018)

Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status
por: Murphy, Kendelle J., et al.
Publicado: (2021)

Endoscopic ultrasound pin-points the precision medicine for pancreatic cancer
por: Zhu, Ping, et al.
Publicado: (2016)

Precision medicine meets the DNA damage response in pancreatic cancer
por: Perkhofer, Lukas, et al.
Publicado: (2018)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
por: Regel, Ivonne, et al.
Publicado: (2020)

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
por: Haque, Muhammad R., et al.
Publicado: (2021)

Future therapies for pancreatic carcinoma: Insights into cancer precision medicine
por: Jiang, Qiu-Yu, et al.
Publicado: (2022)

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
por: Young, Kate, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdc2crbc7og6qkm4c8m605jeqr